Facile Preparation of 3,4-Dihydro-2,1-benzothiazine
2,2-Dioxides and Related Reaction with 1,3-Diiodo-5,5-dimethylhydantoin
under Photochemical Conditions

Atsushi Moroda; Shusuke Furuyama; Hideo Togo

doi:10.1055/s-0028-1216725

LETTER

Facile Preparation of 3,4-Dihydro-2,1-benzothiazine 2,2-Dioxides and Related Reaction with 1,3-Diiodo-5,5-dimethylhydantoin under Photochemical Conditions

Atsushi Moroda, Shusuke Furuyama, Hideo Togo*
Graduate School of Science, Chiba University, Yayoi-cho 1-33, Inage-ku, Chiba 263-8522, Japan
Fax: +81(43)2902792; e-Mail: togo@faculty.chiba-u.jp;

Abstract

All articles of this category

Abstract

3,4-Dihydro-2,1-benzothiazine 2,2-dioxides were easily obtained in good yields by the reaction of N-methyl 2-arylethanesulfonamides with 1,3-diiodo-5,5-dimethylhydantoin (DIH) under irradiation with a tungsten lamp. When N-benzyl 2-phenylethanesulfonamide was treated with DIH under the same conditions, the corresponding N-benzyl 3,4-dihydro-2,1-benzothiazine 2,2-dioxide was obtained in good yield, and the N-benzyl group was easily removed by the treatment with hydrogen in the presence of Pd(OH)₂. On the other hand, treatment of N-3-arylpropyl trifluoromethanesulfonamides with DIH under irradiation with a tungsten lamp provided corresponding N-trifluoromethanesulfonyl-1,2,3,4-tetra-hydroquinolines in good yields.

Key words

3,4-dihydro-2,1-benzothiazine 2,2-dioxide - 1,3-diiodo-5,5-dimethylhydantoin - 1,2,3,4-tetrahydroquinoline - tungsten lamp - irradiation - sulfonamidyl radical

Full Text

References

References and Notes

1a Levy L. Drugs Future 1992, 17: 451

1b Valente C. Guedes RC. Moreira R. Iley J. Gut J. Rosenthal PJ. Bioorg. Med. Chem. Lett. 2006, 16: 4115

1c Zhuang L. Wai JS. Embrey MW. Fisher TE. Egbertson MS. Payne LS. Guare JP. Vacca JP. Hazuda DJ. Felock PJ. Wolfe AL. Stillmock KA. Witmer MV. Moyer G. Schleif WA. Gabryelski LJ. Leonard YM. Lynch JJ. Michelson SR. Young SD. J. Med. Chem. 2003, 46: 453

1d Moree WJ. van der Marel GA. Liskamp RMJ. Tetrahedron Lett. 1991, 32: 409

1e Zecchini GP. Paradisi MP. Torrini I. Lucente G. Gavuzzo E. Mazza F. Pochetti G. Tetrahedron Lett. 1991, 32: 6779

1f Moree WJ. van Gent LC. van der Marel GA. Liskamp RMJ. Tetrahedron 1993, 49: 1133

1g Gennari C. Salom B. Potenza D. Williams A. Angew. Chem., Int. Ed. Engl. 1994, 33: 2067

1h Moree WJ. van der Marel GA. Liskamp RMJ. J. Org. Chem. 1995, 60: 5157

1i Gennari C. Nestler HP. Salom B. Still WC. Angew. Chem., Int. Ed. Engl. 1995, 34: 1765

1j Rough WR. Gwaltney SL. Cheng J. Scheidt KA. McKerrow JH. Hansell E. J. Am. Chem. Soc. 1998, 120: 10994

1k Drews J. Science 2000, 287: 1960

2a Kaiser EM. Kuntson PLA. J. Org. Chem. 1975, 40: 1342

2b Cecchetti V. Fravolini A. Schiaffella F.
J. Heterocycl. Chem. 1982, 19: 1045

2c Harmata M. Kahraman M. J. Org. Chem. 1998, 63: 6845

2d Hanson PR. Probst DA. Robinson RE. Yau M. Tetrahedron Lett. 1999, 40: 4761

3 Togo H. Harada Y. Yokoyama M. J. Org. Chem. 2000, 65: 926

4a Loev B. Kormendy MF. J. Org. Chem. 1965, 30: 3163

4b Blondet D. Pascal JC. Tetrahedron Lett. 1994, 35: 2911

4c Loev B. Kormendy MF. Snader KM. J. Org. Chem. 1966, 31: 3521

5a Iida S. Togo H. Synlett 2007, 407

5b Iida S. Togo H. Tetrahedron 2007, 63: 8274

6 Orazi OO. Corral RA. Bertorello HE. J. Org. Chem. 1965, 30: 1101

7

General Procedure for the Conversion of N -Methyl- or N -Benzyl 2-Arylethanesulfonamides into the Corresponding N -Methyl-3,4-dihydro-2,1-benzothiazine 2,2-dioxides with DIH
1,3-Diiodo-5,5-dimethylhydantoin (0.6 mmol, 228 mg) was added to a soln of N-methyl 2-arylethanesulfonamide (0.5 mmol) in EtOAc (5 mL). The mixture was irradiated with a tungsten lamp (500 W) at 30-40 ˚C for 4 h under an argon atmosphere. After the reaction, the mixture was poured into sat. aq Na₂SO₃ soln and extracted with CHCl₃ three times. Then, the organic layer was dried over Na₂SO₄. After removal of the solvent under reduced pressure, the residue was subjected to preparative TLC on SiO₂ using a mixture of hexane, EtOAc, and CHCl₃ (6:3:1) as eluent.
Typical Procedure for the Reduction of N -Benzyl-3,4-dihydro-2,1-benzothiazine 2,2-dioxide
Palladium hydroxide (20 wt% Pd/C, 200 mg) was added to a soln of N-benzyl-3,4-dihydro-2,1-benzothiazine 2,2-dioxide (1 mmol, 273.4 mg) in EtOAc (4 mL) and EtOH (4 mL). The mixture was stirred at r.t. for 48 h under H₂ atmosphere. After the reaction, the mixture was poured into CHCl₃ and washed with H₂O. The organic layer was dried over Na₂SO₄. After removal of the solvent under reduced pressure, the residue was subjected to preparative TLC on SiO₂ using a mixture of hexane and EtOAc (2:1) as eluent.
N -Methyl-3,4-dihydro-2,1-benzothiazine 2,2-Dioxide Mp 77.0-79.0 ˚C. IR (KBr): 1580, 1490, 1330, 1170 cm^-¹. ^¹H NMR (400 MHz, CDCl₃): δ = 3.30 (s, 3 H), 3.32 (t, J = 6.9 Hz, 2 H), 3.43 (t, J = 6.9 Hz, 2 H), 6.96 (dd, J = 8.0, 1.0 Hz, 1 H), 7.05 (td, J = 7.6, 1.0 Hz, 1 H), 7.16 (dd, J = 7.6, 1.2 Hz, 1 H), 7.27 (m, 1 H). ^¹³C NMR (125 MHz, CDCl₃): δ = 27.90 (s), 31.97 (p), 45.55 (s), 117.47 (t), 122.82 (q), 123.14 (t), 127.88 (t), 129.30 (t), 141.14 (q). MS (EI): m/z = 197 [M⁺]. Anal. Calcd (%) for C₉H₁₁NO₂S: C, 54.80; H, 5.62; N, 7.10. Found: C, 54.74; H, 5.52; N, 7.07.
N -Methyl-7-methyl-3,4-dihydro-2,1-benzothiazine 2,2-Dioxide Mp 78.0-79.0 ˚C. IR (paraffin oil): 1330, 1200, 1159 cm^-¹. ^¹H NMR (400 MHz, CDCl₃): δ = 2.34 (s, 3 H), 3.29 (s, 3 H), 3.32 (t, J = 7.0 Hz, 2 H), 3.40 (t, J = 7.0 Hz, 2 H), 6.77 (s, 1 H), 6.86 (d, J = 7.8 Hz, 1 H), 7.04 (d, J = 7.8 Hz, 1 H). ^¹³C NMR (100 MHz, CDCl₃): δ = 21.27 (p), 27.50 (s), 32.15 (p), 45.55 (s), 118.20 (t), 119.78 (q), 124.02 (t), 129.16 (t), 137.81 (q), 140.92 (q). HRMS-FAB: m/z calcd for C₁₀H₁₃NO₂S: 211.0667 [M]; found: 211.0667 [M⁺].
N -Methyl-7-fluoro-3,4-dihydro-2,1-benzothiazine 2,2-Dioxide Mp 67.0-68.0 ˚C. IR (KBr): 1620, 1590, 1510, 1320, 1300, 1210, 1170, 1140 cm^-¹. ^¹H NMR (400 MHz, CDCl₃): δ = 3.28 (s, 3 H), 3.34 (ddd, J = 7.5, 6.3, 1.4 Hz, 2 H), 3.43 (ddd, J = 7.5, 6.3, 1.4 Hz, 2 H), 6.66 (dd, J = 10.6, 2.4 Hz, 1 H), 6.75 (td, J = 8.2, 2.4 Hz, 1 H), 7.09-7.14 (m, 1 H). ^¹³C NMR (100 MHz, CDCl₃): δ = 27.36 (s), 31.21 (p), 45.68 (s), 104.34 (t, J _C-F = 26.5 Hz), 109.68 (t, J _C-F = 21.5 Hz), 118.05 (q, J _C-F = 4.2 Hz), 130.67 (t, J _C-F = 9.1 Hz), 142.43 (q, J _C-F = 9.9 Hz), 162.30 (q, J _C-F = 245.6 Hz). MS (EI): m/z = 215 [M⁺]. Anal. Calcd (%) for C₉H₁₀FNO₂S: C, 50.22; H, 4.68; N, 6.51. Found: C, 50.03; H, 4.70; N, 6.50.
N -Methyl-7-chloro-3,4-dihydro-2,1-benzothiazine 2,2-Dioxide Mp 93.0-94.0 ˚C. IR (KBr): 1600, 1490, 1330, 1160 cm^-¹. ^¹H NMR (400 MHz, CDCl₃): δ = 3.29 (s, 3 H), 3.34 (t, J = 7.3 Hz, 2 H), 3.43 (t, J = 7.3 Hz, 2 H), 6.93 (d, J = 1.9 Hz, 1 H), 7.02 (dd, J = 8.0, 1.9 Hz, 1 H), 7.09 (d, J = 8.0 Hz, 1 H). ^¹³C NMR (100 MHz, CDCl₃): δ = 27.53 (s), 31.42 (p), 45.52 (s), 117.10 (t), 120.89 (q), 122.96 (t), 130.45 (t), 133.65 (q), 142.11 (q). MS (EI): m/z = 231 [M⁺]. Anal. Calcd (%) for C₉H₁₀ClNO₂S: C, 46.65; H, 4.35; N, 6.05. Found: C, 46.60; H, 4.29; N, 5.94.
N -Methyl-7-bromo-3,4-dihydro-2,1-benzothiazine 2,2-Dioxide Mp 103-105 ˚C. IR (paraffin oil): 1330, 1300, 1200, 1160, 914 cm^-¹. ^¹H NMR (400 MHz, CDCl₃): δ = 3.29 (s, 3 H), 3.32-3.37 (m, 2 H), 3.38-3.43 (m, 2 H), 7.03 (d, J = 8.0 Hz, 1 H), 7.08 (d, J = 1.9 Hz, 1 H), 7.17 (dd, J = 8.0, 1.9 Hz, 1 H). ^¹³C NMR (100 MHz, CDCl₃): δ = 27.68 (s), 31.60 (p), 45.54 (s), 120.07 (t), 121.46 (q), 121.54 (q), 125.99 (t), 130.80 (t), 142.35 (q). HRMS-FAB: m/z calcd for C₉H₁₀NO₂SBr: 274.9616 [M]; found: 274.9598 [M⁺].
N -Benzyl-3,4-dihydro-2,1-benzothiazine 2,2-Dioxide Mp 71.0-73.0 ˚C. IR (KBr): 1600, 1580, 1500, 1460, 1330, 1160 cm^-¹. ^¹H NMR (400 MHz, CDCl₃): δ = 3.25 (t, J = 6.9 Hz, 2 H), 3.44 (t, J = 6.9 Hz, 2 H), 5.00 (s, 2 H), 6.88 (d, J = 8.2 Hz, 1 H), 7.01 (t, J = 7.5, 1.2 Hz, 1 H), 7.10-7.16 (m, 2 H), 7.23-7.37 (m, 5 H). ^¹³C NMR (100 MHz, CDCl₃): δ = 28.16 (s), 45.92 (s), 51.11 (s), 119.09 (t), 123.05 (q), 123.46 (t), 127.09 (t), 127.63 (t), 127.81 (t), 128.79 (t), 129.51 (t), 136.57 (q), 140.26 (q). MS (EI): m/z = 273 [M⁺]. Anal. Calcd (%) for C₁₅H₁₅NO₂S: C, 65.91; H, 5.53; N, 5.12. Found: C, 65.78; H, 5.53; N, 5.02.
3,4-Dihydro-2,1-benzothiazine 2,2-Dioxide Mp 150.0-152.0 ˚C. ^¹H NMR (400 MHz, CDCl₃): δ = 3.32 (t, J = 6.9 Hz, 2 H), 3.49 (t, J = 6.9 Hz, 2 H), 6.45 (s, 1 H), 6.75 (dd, J = 8.1, 1.1 Hz, 1 H), 7.05 (td, J = 7.5, 1.1 Hz, 1 H), 7.17-7.23 (m, 2 H).

8a Omura S. Nakagawa A. Hashimoto H. Oiwa R. Iwai Y. Hirano A. Shibukawa N. Kojima Y. J. Antibiot. 1980, 33: 1395

8b Nakagawa A. Iwai Y. Hashimoto H. Miyazaki N. Oiwa R. Takahashi Y. Hirano A. Shibukawa N. Kojima Y. Omura S. J. Antibiot. 1981, 34: 1408

8c Staub GM. Gloer JB. Wicklow DT. Dowd PF. J. Am. Chem. Soc. 1992, 114: 1015

8d Gellerman G. Babad M. Kashman Y. Tetrahedron Lett. 1993, 34: 1827

8e Magnus P. Parry D. Iliadis T. Eisenbeis SA. Fairhurst RA. J. Chem. Soc., Chem. Commun. 1994, 1543

8f Toyota M. Asoh T. Fukumoto K. Tetrahedron Lett. 1996, 37: 4401

9 Togo H. Hoshina Y. Muraki T. Nakayama H. Yokoyama M. J. Org. Chem. 1998, 63: 5183

10

General Procedure for the Conversion of N -3-Arylpropyl Trifluoromethanesulfonamides into the Corresponding N -(Trifluoromethanesulfonyl)-1,2,3,4-tetrahydroquinolines with DIH
A soln of N-3-arylpropyl trifluoromethanesulfonamide (1.0 mmol) and 1,3-diiodo-5,5-dimethylhydantoin (1.2 mmol, 455.9 mg) in DCE (15 mL) was irradiated with a tungsten lamp (500 W) for 7 h at 60 ˚C under an argon atmosphere. After the reaction, the mixture was poured into a sat. aq Na₂SO₃ soln and extracted with CHCl₃ three times. The organic layer was dried over Na₂SO₄. After filtration, the solvent was removed under reduced pressure, and the residue was subjected to flash column chromatography on SiO₂ using a mixture of hexane, EtOAc, and CHCl₃ (1:10:1) as eluent.
N -(Trifluoromethanesulfonyl)-1,2,3,4-tetrahydro-quinoline Oil. IR (neat): 1580, 1480, 1220, 1200 cm^-¹. ^¹H NMR (400 MHz, CDCl₃): δ = 2.11 (quin, J = 6.4 Hz, 2 H), 2.88 (t, J = 6.4 Hz, 2 H), 3.87 (t, J = 6.4 Hz, 2 H), 7.15-7.22 (m, 3 H), 7.52 (d, J = 7.7 Hz, 1 H). ^¹³C NMR (100 MHz, CDCl₃): δ = 23.39 (s), 26.13 (s), 47.94 (s), 120.11 (q, J _C-F = 328 Hz, CF₃), 123.34 (t), 126.15 (t), 126.79 (t), 129.46 (t), 130.91 (q), 135.31 (q). HRMS (EI): m/z calcd for C₁₀H₁₀F₃NO₂S: 265.0384 [M]; found: 265.0390 [M⁺].
N -(Trifluoromethanesulfonyl)-7-chloro-1,2,3,4-tetra-hydroquinoline
Oil. IR (neat): 1601, 1574, 1454, 1353, 1311, 1025 cm^-¹. ^¹H NMR (500 MHz, CDCl₃): δ = 2.10 (m, 2 H), 2.85 (t, J = 6.8 Hz, 2 H), 3.86 (t, J = 6.0 Hz, 2 H), 7.08-7.15 (m, 2 H), 7.56 (s, 1 H). ^¹³C NMR (125 MHz, CDCl₃): δ = 23.03 (s), 25.80 (s), 47.90 (s), 119.89 (q, J _C-F = 324 Hz, q, CF₃), 123.34 (t), 126.30 (t), 129.08 (q), 130.45 (t), 132.14 (q), 136.08 (q)- HRMS-FAB: m/z calcd for C₁₀H₉ClF₃NO₂S: 298.9995 [M]; found: 299.0006 [M⁺].
N -(Trifluoromethanesulfonyl)-7-methyl-1,2,3,4-tetra-hydroquinoline
Oil. IR (neat): 1620, 1576, 1455, 1393, 1353, 1313 cm^-¹. ^¹H NMR (500 MHz, CDCl₃): δ = 2.09 (m, 2 H), 2.33 (s, 3 H), 2.83 (t, J = 6.9 Hz, 2 H), 3.84 (t, J = 6.1 Hz, 2 H), 6.97 (d, J = 7.4 Hz, 1 H), 7.04 (d, J = 7.4 Hz, 1 H), 7.33 (s, 1 H). ^¹³C NMR (125 MHz, CDCl₃): δ = 21.18 (p), 23.44 (s), 25.69 (s), 47.98 (s), 120.00 (q, J _C-F = 324 Hz, q, CF₃), 123.75 (t), 127.07 (t), 127.81 (q), 129.19 (t), 135.10 (q), 136.65 (q). HRMS-FAB: m/z calcd for C₁₁H₁₂F₃NO₂S: 279.0541 [M]; found: 279.0538 [M⁺].
N -(Trifluoromethanesulfonyl)-7-methoxy-1,2,3,4-tetra-hydroquinoline
Oil. IR (neat): 1617, 1583, 1430, 1293, 1039 cm^-¹. ^¹H NMR (500 MHz, CDCl₃): δ = 2.08 (m, 2 H), 2.81 (t, J = 6.9 Hz 2 H), 3.78 (s, 3 H), 3.85 (t, J = 6.0 Hz, 2 H), 6.73 (dd, J = 8.2, 2.5 Hz, 1 H), 7.05 (d, J = 8.2 Hz, 1 H), 7.12 (d, J = 2.5 Hz, 1 H). ^¹³C NMR (125 MHz, CDCl₃): δ = 23.37 (s), 25.47 (s), 48.11 (s), 55.44 (p), 108.55 (t), 112.72 (t), 120.00 (q, J _C-F = 324 Hz, q, CF₃), 122.58 (q), 130.08 (t), 135.87 (q), 158.15 (q). HRMS-FAB: m/z calcd for C₁₁H₁₂F₃NO₃S: 295.0490 [M]; found: 295.0482 [M⁺].
N -(Trifluoromethanesulfonyl)-7-fluoro-1,2,3,4-tetra-hydroquinoline
Oil. IR (neat): 1614, 1426, 1315, 1029 cm^-¹. ^¹H NMR (500 MHz, CDCl₃): δ = 2.10 (m, 2 H), 2.84 (t, J = 6.9 Hz, 2 H), 3.87 (t, J = 6.0 Hz, 2 H), 6.88 (dt, J = 8.2, 2.4 Hz, 1 H), 7.11 (m, 1 H) 7.33 (dd, J = 10.7, 2.4 Hz, 1 H). ^¹³C NMR (125 MHz, CDCl₃): δ = 23.07 (s), 25.74 (s), 47.96 (s), 110.52 (t, J = 26 Hz), 113.28 (t, J = 21 Hz), 119.92 (q, J _C-F = 323 Hz, q, CF₃), 126.00 (q), 130.50 (t, J = 9 Hz), 159.86 (q), 161.81 (q). HRMS-FAB: m/z calcd for C₁₀H₉F₄NO₂S: 283.0290 [M]; found: 283.0280 [M⁺].